The EMA (European Medicines Agency) has now authorized the use of the covid-19 pill of Pfizer for the purpose of treating the adult population of the European Union at the risk of the serious illness.
The endorsement has now been allowing the member nations of the European Union (EU) for the purpose of deploying the covid-19 drug after the European Medicines Agency (EMA) for the purpose of giving the guidance for the emergency use of the drug in the year 2021.
The European Medicines Agency (EMA) of the European Union said in a statement that, the Committee for Medicinal Products for Human Use (CHMP) has also recommended the grant for a conditional marketing authorization for the medicine known as Paxlovid for the purpose of treating the novel corona virus in the adult population who are not requiring the supplemental oxygen and also at the increasing risk of the disease that becoming serious.
The medicine known as Paxlovid has been has been the very first oral antiviral drug has now recommended in the treatment of the novel corona virus in the European, and it has also been consisting of the two substances that is active and packages together. One of the first substances has been enabling to remain longer in the body at the levels that has been affecting the multiplication of the corona virus.
Most of the patients are also involved in the study had been infected with the Delta variant of the novel corona virus.
Writing is a medium to express feelings and convey facts. A creative mind never rests in peace and this amazing platform gives me the freedom to write about what I like most.
I’ve been a writer/blogger for the last twelve years and have covered technology-related topics. However, I also have considerable years of experience in writing for various domains – Technology, Beauty, Fashion, Pharmaceutical, human psychology etc. Technology is my forte.
I’ve handled many interesting projects. Writing is my passion. As an author, I’ve learned a lot in my long journey of penning down my thoughts!
